Luca Licata
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- HER2/EGFR in Cancer Research
- Cancer Research top 10%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Papers in
- Oncology 16
- Cancer Immunotherapy and Biomarkers 7
- Cancer Treatment and Pharmacology 4
- HER2/EGFR in Cancer Research 4
-
- Advanced Breast Cancer Therapies 5
- Co-authors
- Giampaolo Bianchini (17 shared papers)Carmine De Angelis (3 shared papers)Luca Gianni (5 shared papers)Giulia Viale (8 shared papers)Antonio Giordano (1 shared paper)Filipa Lynce (1 shared paper)Antônio Bernardo (6 shared papers)Judy E. Garber (1 shared paper)
- Journals
- Annals of Oncology (3 papers)Frontiers in Oncology (2 papers)Journal of Clinical Oncology (2 papers)Cancer Research (2 papers)Clinical Cancer Research (1 paper)
- Partner nations
- ItalyUnited StatesGermany
In The Last Decade
Luca Licata
21 papers receiving 927 citations
Luca Licata's Hit Papers
Peers
Comparison fields: 5 of 87
- Oncology 484
- Cancer Research 265
- Immunology 187
- Pulmonary and Respiratory Medicine 200
- Molecular Biology 402
Countries citing papers authored by Luca Licata
This map shows the geographic impact of Luca Licata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luca Licata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luca Licata more than expected).
Fields of papers citing papers by Luca Licata
This network shows the impact of papers produced by Luca Licata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luca Licata. The network helps show where Luca Licata may publish in the future.
Co-authors
The 25 scholars most cited alongside Luca Licata, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Treatment landscape of triple-negative breast cancer — expanded options, evolving needs Hit paper breakdown → | 2021 | 801 |
| 2 | 2024 | 39 | |
| 3 | 2020 | 28 | |
| 4 | 2019 | 12 | |
| 5 | 2023 | 9 | |
| 6 | 2023 | 6 | |
| 7 | 2024 | 6 | |
| 8 | 2018 | 6 | |
| 9 | 2019 | 5 | |
| 10 | 2024 | 4 | |
| 11 | 2020 | 3 | |
| 12 | 2023 | 2 | |
| 13 | 2022 | 2 | |
| 14 | 2024 | 2 | |
| 15 | 2016 | 1 | |
| 16 | 2018 | 1 | |
| 17 | 2017 | 1 | |
| 18 | 2024 | 1 | |
| 19 | 2021 | 1 | |
| 20 | 2021 | 1 |
About Luca Licata
Luca Licata is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Surgery and Genetics, having authored 24 papers that have together received 932 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (7 papers), Cancer Genomics and Diagnostics (7 papers), Advanced Breast Cancer Therapies (5 papers), Cancer Treatment and Pharmacology (4 papers), HER2/EGFR in Cancer Research (4 papers), Breast Cancer Treatment Studies (3 papers), BRCA gene mutations in cancer (3 papers) and Economic and Financial Impacts of Cancer (2 papers). The work is most often cited by research in Oncology (484 citations), Cancer Research (265 citations), Immunology (187 citations), Pulmonary and Respiratory Medicine (200 citations) and Molecular Biology (402 citations). Luca Licata has collaborated with scholars based in Italy, United States and Germany. Frequent co-authors include Giampaolo Bianchini, Carmine De Angelis, Luca Gianni, Giulia Viale, Antonio Giordano, Filipa Lynce, Antônio Bernardo, Judy E. Garber, Federica Giugliano and Carmen Criscitiello. Their work appears in journals such as Annals of Oncology, Frontiers in Oncology, Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.